Magnisense develops and markets a new generation of immunoassays for human and animal diagnostics, food safety and environmental protection. These innovative immunoassays deliver the accuracy of laboratory testing with the ease of use of rapid test methods currently on the market.

MIAtek™ technology presents an unparalleled opportunity for rapid test development. The performance improvements over existing immunoassays enable the development of sensitive, robust, rapid and easy to use diagnostic tests.
It is the mission of Magnisense to license the MIAtek™ technology to firms in the position to best develop and commercialize tests for a broad spectrum of targets.

MIAtek™ leverages proven technology to reduce technical risk. The selective binding of antibody to antigen, the behaviour of magnetic beads in flux, even the performance of reagents and methods have been documented and proven in use. The true innovation of MIAtek™ exists in the unique method of analysis that enables these existing technologies to yield superior results over an extended analyte range.